Theseus Pharmaceuticals, Inc. — Form D/A
Theseus Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2021-02-04. The offering totals $22.1M, of which $22.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-02-04
- Form: D/A
- Accession: 0001745020-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $22.1M
- Amount sold: $22.1M
- Investors: 3
- Date of first sale: 2018-06-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315789
Issuer
- Name: Theseus Pharmaceuticals, Inc.
- CIK: 0001745020
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 210 Broadway, Suite 201, Cambridge, MA, 02139
- Phone: 2127396493
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Iain Dukes | Director | Cambridge, MA |
| Iain Dukes | Executive Officer | Cambridge, MA |
| William C Shakespeare | Director | Cambridge, MA |
| Michael C Rome | Director | San Francisco, CA |
| Carl C Gordon | Director | New York, NY |
Other filings by this issuer (2)
More